clofarabine preconditioning followed by allogeneic transplantation with tbi & ptcy for r/r aml
Published 1 year ago • 71 plays • Length 3:34Download video MP4
Download video MP3
Similar videos
-
2:59
low-intensity venetoclax-based preconditioning followed by sequential allosct for r/r aml or hr-mds
-
1:01
preconditioning prior to non-myeloablative matched sibling donor hsct in patients with scd
-
2:45
continuity of care for patients with hematological predispositions to aml
-
2:29
epitope editing enables the use of novel immunotherapies for aml
-
1:02
maintenance therapy following treatment for amyloidosis
-
2:11
update on phase i/ii study of azacitidine, venetoclax and gilteritinib in patients with flt3 aml
-
9:11
chimeric antigen receptor car technique - creative biolabs (original version)
-
4:51
the current frontline treatment strategy in multiple myeloma
-
11:48
fab classification of aml pathology made easy | acute myeloid leukemia classification|#speedymedical
-
1:24
sequencing of btk inhibitors in cll
-
1:30
hovon-100: clofarabine added to prephase and consolidation therapy in adult patients with all
-
2:23
emerging therapies for ebv-driven ptld & insights into the allele trial
-
1:03
using bispecific antibodies instead of chemotherapy to reach pre-transplant remission in b-all
-
1:30
a phase i trial of voruciclib /- venetoclax for the treatment of nhl and aml
-
1:09
ibrutinib added to autosct conditioning and consolidation for patients with abc-dlbcl
-
1:34
advances and unmet needs in second-line treatment of dlbcl
-
4:39
aml & mds: mac or ric?
-
0:38
optimal time for allo-hsct in aml
-
4:24
cd19 cars for aml
-
7:28
mbg453 with hypomethylating agents in aml and high-risk mds
-
1:04
clad-ldac-ven induction therapy in aml: insights from a phase ii trial
-
1:05
reprogramming leukemia cells into apcs as a novel therapeutic strategy for b-all